Nubiance was founded by a cosmetic surgeon who identified a lack of adapted skincare solutions for his patients, particularly in post-operative care and for the specific needs of melanin-rich skin. To bring the project to life, he joined forces with a specialist in cosmetic raw materials and an expert in international distribution, notably across Africa. Leveraging this expertise, the brand initially grew through export markets, with a strong presence in Africa, before strategically refocusing on the French market seven years ago. Today, Nubiance is distributed in 116 countries worldwide.
Designed for diverse complexions
The Nubiance skincare range is designed for melanin-rich skin — whose specific characteristics are still insufficiently considered in dermo-cosmetic research, prevention, and innovation. The brand’s approach stems from a simple observation: skin function varies according to phototypes, thus determining the effectiveness of skincare products.
"Dark, mixed, and tan skin tones display specific pigmentation and scarring responses that can affect skin sensitivity and contribute to the appearance of long-lasting marks,” explains Nubiance. Despite these distinct characteristics, few brands develop products specifically formulated and clinically tested for these phototypes.
Founded in 2016, Nubiance has adopted an expert, science-driven positioning centered on clinically tested products formulated with recognized active ingredients. As part of its R&D strategy, melanin-rich phototypes — ranging from Mediterranean to sub-Saharan skin tones — which represent the brand’s core target audience, serve as the scientific reference standard in product development.
As a result, the specific biological mechanisms of these skin types are incorporated into formulations from the earliest stages of development, enabling targeted action on pigmentation, inflammation, skin barrier function, and overall skin balance.
"Relevant skincare stems from a deep understanding of the skin, scientific rigor, and adaptation to real-life uses," highlights Arnita Wofford, CEO of Nubiance. "Today, performance lies in the ability to combine scientific expertise with ease of use. Science should enhance the experience, not complicate it."
Targeting hyperpigmentation
Among the key concerns associated with melanin-rich skin, hyperpigmentation remains Nubiance’s primary area of focus. It is a particularly prevalent issue for darker skin tones, especially following sun exposure during the summer months.
“Many brands offer anti-dark spot treatments, but very few are specifically designed for and tested on these skin types,” emphasizes Arnita Wofford. “Unsuitable formulas can even worsen pigmentation problems,” she continues.
On this point, Nubiance emphasizes the importance of a holistic approach, viewing the skin as an interconnected ecosystem rather than addressing concerns in isolation.
The brand currently offers twelve products across three ranges, the most developed of which remains the anti-dark spot range, the brand’s original line, which includes an anti-dark spot body lotion that regulates hyperpigmentation, an eye contour cream targeting hollows, puffiness, and pigmented dark circles, and an anti-dark spot serum that reduces dark spots thanks to fruit acids.
A new brightening anti-dark spot face cream was launched in 2025. It addresses a common practice among consumers who were using the body lotion on their face, a practice deemed unsuitable due to the sensitivity of facial skin. The brand has therefore formulated a new product to better address facial hyperpigmentation.
A targeted pharmacy retail strategy
Nubiance is currently distributed through approximately 800 pharmacies and parapharmacies across France. The brand also benefits from an established network of pharmacy and parapharmacy partners in the French overseas territories, Africa, Vietnam, and the Middle East.
“Our ambition is to expand internationally and strengthen brand visibility while remaining anchored in a trusted healthcare environment, supported by the guidance of pharmacists and pharmacy advisors,” explains Arnita Wofford. To support this strategy, the brand invests heavily in professional training, offering regularly updated educational videos and marketing tools designed to help pharmacy teams better assist consumers with complex skin concerns.
A high-potential, still under-educated market
Although concerns related to melanin-rich skin are longstanding, they continue to receive limited visibility within the skincare market. Many consumers remain unaware that products specifically formulated for their skin needs even exist. Against this backdrop, Nubiance aims not only to strengthen its brand awareness, but also to play an active role in educating and structuring the market.
The market potential is significant on a global scale, as these concerns affect consumers across numerous regions, including Africa, the Middle East, Asia — particularly China, Vietnam, and Indonesia — as well as Europe and the United States. The U.S. market represents a key growth driver for Nubiance, which aims to become, within the next three years, “the equivalent of La Roche-Posay for melanin-rich skin,” says Arnita Wofford.
Beyond its product portfolio, Nubiance is positioning itself within a broader shift in the beauty and dermo-cosmetic industry, where addressing the specific needs of melanin-rich skin is becoming an increasingly important challenge. By integrating these phototypes from the earliest stages of formulation, the brand seeks to help advance research standards and clinical practices across the sector.
